Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2007 Oct 29;64(24):3271–3281. doi: 10.1007/s00018-007-7357-7

Phytanic acid impairs mitochondrial respiration through protonophoric action

J C Komen 1,, F Distelmaier 2,3,4, W J H Koopman 2, R J A Wanders 1, J Smeitink 3,5, P H M G Willems 2
PMCID: PMC11135980  PMID: 17968498

Abstract.

Refsum disease is a rare, inherited neurodegenerative disorder characterized by accumulation of the dietary branched-chain fatty acid phytanic acid in plasma and tissues caused by a defect in the alphaoxidation pathway. The accumulation of phytanic acid is believed to be the main pathophysiological cause of the disease. However, the exact mechanism(s) by which phytanic acid exerts its toxicity have not been resolved. In this study, the effect of phytanic acid on mitochondrial respiration was investigated. The results show that in digitonin-permeabilized fibroblasts, phytanic acid decreases ATP synthesis, whereas substrate oxidation per se is not affected. Importantly, studies in intact fibroblasts revealed that phytanic acid decreases both the mitochondrial membrane potential and NAD(P)H autofluorescence. Taken together, the results described here show that unesterified phytanic acid exerts its toxic effect mainly through its protonophoric action, at least in human skin fibroblasts.

Keywords. Phytanic acid, Refsum disease, mitochondria, membrane potential, oxidative phosphorylation

Footnotes

Received 4 August 2007; received after revision 26 September 2007; accepted 10 October 2007

J. C. Komen, F. Distelmaier: These authors contributed equally to this work.


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES